{"id":545598,"date":"2024-07-11T19:54:05","date_gmt":"2024-07-12T02:54:05","guid":{"rendered":"https:\/\/nai500.com\/?p=545598"},"modified":"2024-07-11T19:54:05","modified_gmt":"2024-07-12T02:54:05","slug":"%e7%a5%9e%e5%a5%87%e7%9a%84glp-1%e9%9d%b6%e5%90%91%e8%8d%af%e7%89%a9%ef%bc%8c%e5%8d%b3%e5%b0%86%e5%ad%95%e8%82%b2%e6%96%b0%e7%9a%84%e5%87%8f%e8%82%a5%e8%8d%af%e5%8f%8c%e9%9b%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2024\/07\/%e7%a5%9e%e5%a5%87%e7%9a%84glp-1%e9%9d%b6%e5%90%91%e8%8d%af%e7%89%a9%ef%bc%8c%e5%8d%b3%e5%b0%86%e5%ad%95%e8%82%b2%e6%96%b0%e7%9a%84%e5%87%8f%e8%82%a5%e8%8d%af%e5%8f%8c%e9%9b%84\/","title":{"rendered":"\u795e\u5947\u7684GLP-1\u9776\u5411\u836f\u7269\uff0c\u5373\u5c06\u5b55\u80b2\u65b0\u7684\u201c\u51cf\u80a5\u836f\u53cc\u96c4\u201d"},"content":{"rendered":"<p>\u8fd1\u5e74\u6765\uff0cGLP-1\u9776\u5411\u836f\u7269\u5728\u80a5\u80d6\u6cbb\u7597\u9886\u57df\u6210\u4e3a\u4e86\u7099\u624b\u53ef\u70ed\u7684\u7814\u7a76\u65b9\u5411\u3002\u7ee7\u8bfa\u548c\u8bfa\u5fb7Novo Nordisk\uff08NYSE:NVO\uff09\u548c\u793c\u6765Eli Lilly and Co\uff08NYSE:LLY\uff09\u5404\u81ea\u63a8\u51fa\u51cf\u80a5\u836fWegovy\u548cZepbound\u4e4b\u540e\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ALT\">Altimmune Inc.\uff08NASDAQ:ALT\uff09<\/a>\u548cViking Therapeutics Inc\uff08NASDAQ:VKTX\uff09\u8fd9\u4e24\u5bb6\u751f\u7269\u6280\u672f\u516c\u53f8\u4e5f\u5728\u8fd9\u4e00\u9886\u57df\u5c55\u73b0\u51fa\u5f3a\u5927\u7684\u7ade\u4e89\u529b\u3002<\/p>\n<p>\u5982\u679c\u8bf4\u8bfa\u548c\u8bfa\u5fb7\u548c\u793c\u6765\u662f\u76ee\u524d\u7f8e\u80a1\u5e02\u573a\u4e0a\u7684\u201c\u51cf\u80a5\u836f\u53cc\u96c4\u201d\uff0cAltimmune\u548cViking Therapeutics\u6709\u671b\u6210\u4e3a\u672a\u6765\u7684\u53cc\u96c4\uff0c\u4f9d\u636e\u662f\u8fd9\u4e24\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u90fd\u62e5\u6709\u5f3a\u5927\u5b9e\u529b\u7684\u5728\u7814\u51cf\u80a5\u836f\uff0c\u800c\u4e14\u73b0\u91d1\u5145\u8db3\u3002<\/p>\n<h2>Viking Therapeutics\uff1a\u51cf\u80a5\u901f\u5ea6\u66f4\u5feb<\/h2>\n<p>Viking Therapeutics\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269VK2735\u5df2\u7ecf\u5728\u51762b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u663e\u8457\u6210\u6548\u3002\u6570\u636e\u663e\u793a\uff0c\u4e0e\u76ee\u524d\u5e02\u573a\u4e0a\u7684\u51cf\u80a5\u836f\u76f8\u6bd4\uff0cVK2735\u7684\u51cf\u80a5\u901f\u5ea6\u660e\u663e\u66f4\u5feb\uff0c\u4e14\u526f\u4f5c\u7528\u76f8\u5f53\u3002\u7ecf\u8fc7\u4ec513\u5468\u7684\u6cbb\u7597\u540e\uff0c\u53d7\u8bd5\u8005\u7ecf\u5b89\u6170\u5242\u8c03\u6574\u540e\u7684\u4f53\u91cd\u5e73\u5747\u51cf\u5c11\u4e8613.1%\u3002<\/p>\n<p>\u66f4\u4ee4\u4eba\u632f\u594b\u7684\u662f\uff0cVK2735\u5e76\u672a\u663e\u793a\u51fa\u51cf\u80a5\u6548\u679c\u7684\u201c\u5e73\u53f0\u671f\u201d\uff0c\u8fd9\u610f\u5473\u7740\u6cbb\u7597\u6709\u671b\u5e26\u6765\u4f53\u91cd\u7684\u6301\u7eed\u51cf\u8f7b\u3002\u6b64\u5916\uff0cViking\u7684VK2735\u53e3\u670d\u836f\u7269\u6b63\u5904\u4e8e\u65e9\u671f\u7814\u53d1\u9636\u6bb5\uff0c\u800c\u4e14\u521d\u671f\u6570\u636e\u8868\u73b0\u4e5f\u4e0d\u5f31\u4e8e\u6ce8\u5c04\u5242\u3002\u76ee\u524d\u5e02\u573a\u4e0a\u9500\u552e\u706b\u7206\u7684Wegovy\u548cZepbound\u90fd\u662f\u6ce8\u5c04\u5242\uff0c\u5982\u679c\u8be5\u516c\u53f8\u7684\u53e3\u670d\u51cf\u80a5\u836f\u6210\u529f\u4e0a\u5e02\uff0c\u51ed\u501f\u7740\u4fbf\u5229\u6027\u8fd9\u6b3e\u836f\u65e0\u7591\u53ef\u4ee5\u83b7\u5f97\u66f4\u5927\u7684\u5e02\u573a\u4efd\u989d\u3002<\/p>\n<p>Viking\u76ee\u524d\u8d44\u91d1\u5b9e\u529b\u975e\u5e38\u96c4\u539a\uff0c\u62e5\u67099.63\u4ebf\u7f8e\u5143\u7684\u73b0\u91d1\u3001\u77ed\u671f\u6295\u8d44\u53ca\u73b0\u91d1\u7b49\u4ef7\u7269\uff0c\u800c\u8fc7\u53bb12\u4e2a\u6708\u7684\u603b\u652f\u51fa\u4ec5\u4e3a1.14\u4ebf\u7f8e\u5143\u3002\u516c\u53f8\u6ca1\u6709\u8d1f\u503a\uff0c\u8fd9\u4e5f\u610f\u5473\u7740VK2735\u7684\u7814\u53d1\u548c\u5546\u4e1a\u5316\u6ca1\u6709\u878d\u8d44\u7684\u9700\u6c42\u3002<\/p>\n<h2>Altimmune\uff1a\u51cf\u8102\u4e0d\u51cf\u808c<\/h2>\n<p>\u4e0eViking\u76f8\u6bd4\uff0cAltimmune\u7684GLP-1\u7ba1\u7ebf\u7565\u5fae\u9886\u5148\u534a\u6b65\u3002\u8be5\u516c\u53f8\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u521a\u521a\u5b8c\u62102\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u9884\u8ba1\u5c06\u5728\u7b2c\u4e09\u5b63\u5ea6\u4e0e\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u4f1a\u9762\uff0c\u63a2\u8ba8\u8fdb\u51653\u671f\u4e34\u5e8a\u7684\u4e8b\u5b9c\u3002<\/p>\n<p>\u76ee\u524dAltimmune\u53d1\u5e03\u7684\u6570\u636e\u5e76\u672a\u6e05\u6670\u663e\u793a\u5b83\u7684\u5019\u9009\u836f\u7269\u51cf\u80a5\u901f\u5ea6\u4f18\u4e8eViking\u7684VK2735\uff0c\u4f46\u540c\u6837\u672a\u663e\u793a\u5e73\u53f0\u671f\u30022\u671f\u8bd5\u9a8c\u768448\u5468\u5185\uff0c\u6700\u9ad8\u5242\u91cf\u7ec4\u5e73\u5747\u51cf\u91cd15.6%\u3002\u4e0d\u8fc7\u5c24\u5176\u503c\u5f97\u4e00\u63d0\u7684\u662f\uff0cAltimmune\u7684\u5019\u9009\u836f\u7269\u51cf\u8102\u4e0d\u51cf\u808c\uff0c\u8fd9\u662f\u5176\u4ed6\u7ade\u4e89\u836f\u7269\u65e0\u6cd5\u6bd4\u62df\u7684\u4f18\u52bf\u3002\u6211\u4eec\u77e5\u9053\uff0c\u808c\u8089\u6d41\u5931\u4f1a\u5bfc\u81f4\u5404\u79cd\u5065\u5eb7\u95ee\u9898\uff0c\u56e0\u6b64\u5982\u679c\u901a\u8fc7\u5ba1\u6279\uff0c\u8be5\u5019\u9009\u836f\u7269\u5c06\u6210\u4e3a\u8001\u5e74\u4eba\u3001\u808c\u8089\u7ef4\u62a4\u969c\u788d\u8005\u4ee5\u53ca\u884c\u52a8\u4e0d\u4fbf\u4eba\u58eb\u7684\u9996\u9009\u6cbb\u7597\u65b9\u6848\u3002<\/p>\n<p>Altimmune\u76ee\u524d\u4e5f\u6ca1\u6709\u8d1f\u503a\uff0c\u62e5\u67091.82\u4ebf\u7f8e\u5143\u7684\u73b0\u91d1\u3001\u73b0\u91d1\u7b49\u4ef7\u7269\u53ca\u6295\u8d44\uff0c\u8fc7\u53bb12\u4e2a\u6708\u7684\u603b\u652f\u51fa\u4e3a8900\u4e07\u7f8e\u5143\u3002\u867d\u7136\u5728\u836f\u7269\u5546\u4e1a\u5316\u524d\u9700\u8981\u989d\u5916\u878d\u8d44\uff0c\u4f46\u77ed\u671f\u5185\u8d22\u52a1\u72b6\u51b5\u5c1a\u5c5e\u7a33\u5b9a\u3002<\/p>\n<h2>Viking\u7684\u98ce\u9669\u66f4\u4f4e<\/h2>\n<p>Viking Therapeutics\u548cAltimmune\u90fd\u662f\u975e\u5e38\u4f18\u8d28\u7684\u51cf\u80a5\u836f\u6f5c\u529b\u80a1\uff0c\u5b83\u4eec\u7684\u5728\u7814GLP-1\u9776\u5411\u836f\u7269\u5747\u6709\u671b\u5728\u672a\u6765\u4e24\u5e74\u5185\u5b8c\u6210\u4e34\u5e8a\u8bd5\u9a8c\u5e76\u83b7\u6279\u4e0a\u5e02\u3002\u4f46\u662f\u76f8\u6bd4\u4e4b\u4e0b\uff0cViking\u7684\u80a1\u7968\u4f30\u503c\u6700\u8fd1\u62ac\u5347\u660e\u663e\uff0c\u4f46\u8be5\u516c\u53f8\u73b0\u91d1\u50a8\u5907\u66f4\u52a0\u5145\u8db3\uff0c\u7814\u53d1\u7ba1\u7ebf\u66f4\u52a0\u591a\u5143\u5316\uff0c\u62b5\u5fa1\u4e0d\u786e\u5b9a\u6027\u7684\u80fd\u529b\u66f4\u5f3a\u3002\u8fd9\u6837\u770b\u6765\uff0cAltimmune\u56e0\u4e3a\u5168\u62bcGLP-1\u9776\u5411\u836f\u7269\uff0c\u98ce\u9669\u66f4\u9ad8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u5e74\u6765\uff0cGLP-1\u9776\u5411\u836f\u7269\u5728\u80a5\u80d6\u6cbb\u7597\u9886\u57df\u6210\u4e3a\u4e86\u7099\u624b\u53ef\u70ed\u7684\u7814\u7a76\u65b9\u5411\u3002\u7ee7\u8bfa\u548c\u8bfa\u5fb7Novo Nordisk\uff08NYSE [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":448884,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,2155,925,2140],"class_list":["post-545598","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-2155","tag-925","tag-2140","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/545598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=545598"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/545598\/revisions"}],"predecessor-version":[{"id":545603,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/545598\/revisions\/545603"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/448884"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=545598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=545598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=545598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}